The ERS
Task Force on the Diagnosis and Management of Obstructive
Sleep-Disordered Breathing (SDB) in Childhood has published a new
document detailing a stepwise management approach for SDB in children
aged 2–18.
The
seven-step management approach covers topics such as reported symptoms,
morbidities, treatment indications and follow-up evaluations. The
document also takes into account the available diagnostic facilities and
accepted treatment policies in different European countries, describing
diagnostic modalities that can be used as alternatives for settings
where polysomnography is not available.
This document summarises the conclusions of a European Respiratory
Society Task Force on the diagnosis and management of obstructive sleep
disordered breathing (SDB) in childhood and refers to children aged
2–18 years. Prospective cohort studies describing the natural history of
SDB or randomised, double-blind, placebo-controlled trials regarding
its management are scarce. Selected evidence (362 articles) can be
consolidated into seven management steps. SDB is suspected when symptoms
or abnormalities related to upper airway obstruction are present (step
1). Central nervous or cardiovascular system morbidity, growth failure
or enuresis and predictors of SDB persistence in the long-term are
recognised (steps 2 and 3), and SDB severity is determined objectively
preferably using polysomnography (step 4). Children with an
apnoea–hypopnoea index (AHI) >5 episodes·h−1, those with an AHI of 1–5 episodes·h−1 and the presence of morbidity or factors predicting SDB persistence, and children with complex conditions (e.g.
Down syndrome and Prader–Willi syndrome) all appear to benefit from
treatment (step 5). Treatment interventions are usually implemented in a
stepwise fashion addressing all abnormalities that predispose to SDB
(step 6) with re-evaluation after each intervention to detect residual
disease and to determine the need for additional treatment (step 7).
Link:
No comments:
Post a Comment